Agarwal, R., A. Goel, J. Rai, and N. C. Kajal. “Pharmacovigilance of First Line Anti-Tubercular Therapy in Category I Patients of Pulmonary Tuberculosis”. International Journal of Basic & Clinical Pharmacology, vol. 6, no. 3, Feb. 2017, pp. 643-7, doi:10.18203/2319-2003.ijbcp20170829.